Building molecule from Idea! ATLANCHIM PHARMA is a chemistry-based CRO (Contract Research Organization) conducting confidential custom synthesis of complex molecules tailored to customer specifications. Our team provides multi-step organic synthesis from a milligram to several gram scale. CRO, Custom synthesis, Chemistry, Research & Development, Organic chemistry, Medicinal chemistry, Reproduction services, Stable isotope labeling, Organic synthesis, Heterocycle synthesis, Carbohydrate chemistry, Peptide synthesis, Impurety synthesis, and Hit to lead

27 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Bio sourced materials

Expert services in supercritical CO2 and nanomedicines for the life science industry StaniPharm is a Contract Development and Manufacturing Organization (CDMO). Pioneers in supercritical CO2 technologies, we operate a state-of-the-art facility and provide the life science industry with flexible development and GMP manufacturing services. We move your products from idea to market: botanical extracts, challenging polymers and lipids, nanomedicines, tailored drug particles. Keywords : nanoparticles, medicinal cannabis, particle and crystal engineering, crystallization, polymers, lipids, supercritical fluids, purification, formulation, impregnation, sterilization, GMP manufacturing, poorly soluble drugs, polymorphism, CDMO drug delivery, supercritical fluids, formulation, nanoparticles, GMP manufacturing, poorly soluble drugs, sterilization, impregnation, …

19 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

#BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine New ideas, new innovations, new ways of thinking for the medical device industry. We are a pharmaceutical company specialized in the discovery, clinical development, production and commercialization of innovative products in the field of regenerative medicine. At Bioxis Pharmaceuticals, we contribute to transform science into groundbreaking medical device that meet doctors need to improve the health and well-being of their patients in the field of dermatology and aesthetic medicine. Medical Device, Dermatology, Aesthetic, Cosmetic surgery, Regenerative medicine, Ultra-pure chitosan, and Hyaluronic Acid

301 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology

Dermo-innovation Feeligreen is a technology startup developing safe and effective micro-current devices for a wide range of cosmetic and therapeutic applications. With applications ranging from anti-ageing to wound healing, it develops and sells innovative drug-delivery systems to TIer1 pharmaceutical laboratories medical devices, therapeutics, cosmetics, and skincare

134 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology

We supply the world with active pharmaceutical ingredients Farmabios is a leading global manufacturer of highly potent active pharmaceutical ingredients. With decades of steroid and complex chemistry expertise, and newly opened research and development projects in various fields, Farmabios provides bespoke products and solutions, understanding customer needs. Steroids, Chemistry, Active Pharmaceutical Ingredients, Hormones, Drug Substances, Healthcare, Pharmaceuticals, and Bespoke products

62 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Technologies for Efficient Tooling For more than 50 years we manufacture multi-cavity molds (>128) for drug delivery devices. plastique, moule d'injection, injection mold, medical, diagnostic, pharmaceutical, design control, and metrology

90 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Research center & amp; Health development Bionoveo offers project leaders, industrial or academic, biological, technical and methodological skills and resources necessary for the development of new therapeutic and diagnostic strategies, as well as their production processes.

283 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

You have the motivation, we have the rest! We are developing a new form of administration of active ingredients by vaporization. We operate in respiratory health around the smoking cessation mainly and related diseases such as COPD/Asthma as well as pain management. Our development is practiced on a medical system by vaporization coupled with liquid drug formulations. Biotechnology, CBD, health, pharmaceuticals, vaporization, sedem, respiratory health, smoking cessation, BPCO, and pain management

22 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Biomanufacturing services Naobios provides bioprocess development and contract manufacturing services for viral vaccines and viral vectors. The company was acquired by Clean Biologics on March 1st, 2019 and now supports clients for process development and the manufacture of preclinical and clinical batches.

159 similar entities Type: Startup Activities: manufacturing deeptech Technologies: Synthetic Biology

Created in 2013, CleveXel Pharma is a pharmaceutical company with an innovative business model based on maximizing the marketing potential of disruptive molecules in exchange for a stake in the partner's equity or for the gradual purchase of a license. LIFE SCIENCES, PHARMACEUTICAL DEVELOPMENT, CLINICAL RESEARCH, and QUALITY / COMPLIANCE

56 similar entities Type: Startup Activities: biotech deeptech martech

AbLeads is a young biotech startup developing innovative solutions in Oncology, through the generation of novel, personalized therapeutic antibodies. Learn More on https://ableads.fr Biotechnology, Oncology, Immunotherapy, Therapeutic Antibodies, and Personalized Medicine

574 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Advancing healthcare through innovative adenosine receptor-based drugs Palobiofarma S.L. is a Spanish biopharmaceutical company dedicated to discovering and developing innovative drugs based on the modulation of adenosine receptors.

226 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Regenerative Medicine - Growth Disregulation - Oncology REGULAXIS is a French innovative biotechnology company based at BIOCITECH the technology park of life science of Paris North area. The company is engaged in the research, development and licensing of innovative synthetic molecules for use in human therapies. Its mission is to grant licenses of innovative molecules in a pharmaceutical company after the establishment of a phase II clinical record. REGULAXIS leads its R&D on its own premises, particularly in regard to biochemical and biological experiments, and keeps the mastery of the chemical synthesis of its therapeutic molecules. The company develops its …

251 similar entities Type: Startup Activities: biotech healthtech Technologies: Synthetic Biology

Syndivia is committed to enhancing treatment options for cancer patients with solid tumors by leveraging the distinctive properties of targeted DAR1 antibody-drug conjugates, which offer improved tumor penetration, stability, and efficacy. Drug development, Biotechnology, Pharmaceuticals, Antibody-drug conjugates, DAR1 ADC, and ADC

156 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Entreprise de dispositif médical de diagnostic in vitro : Noratest® In vitro diagnostic medical device Diagnostic, Innovation, Maladies neurodégénératives, Alzheimer, Neurosciences, Entreprise, and Entrepreneuriat

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Leading biotech in the development of innovative microbiome-based biotherapies YSOPIA Bioscience is a clinical-stage biotech company developing cutting-edge biotherapies based on the gut microbiome. Our goal is to bring safe & efficient solutions to patients with high unmet medical needs. Microbiome, Obesity, Gut modulator, Cardiometabolism, Cardiometabolic diseases, Microbiota, and Gut microbiota

200 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Dicot is a pharmaceutical company focused on increasing well-being through innovations that enhance sexual health. Dicot is a pharmaceutical company focused on increasing quality of life and well-being through innovations that enhance sexual health. The company develops and manufactures medicines for the treatment of erectile dysfunction and premature ejaculation. The company's lead candidate, LIB-01, is in clinical stage of development. erectile dysfunction, biopharma, premature ejaculation, drug development, pharma, sexual health, lifestyle , drug discovery, lifestyle, drug discovery, drugs from nature, and biopharmaceutical

22 similar entities Type: Startup Activities: manufacturing deeptech biotech healthtech Technologies: Synthetic Biology

BS MEDICAL TECH INDUSTRY is a medical devices company based out of 2 RUE DE L'AVENIR, Niederroedern, Grandest, France. dispositif médical, Innovation, R&D, Urologie, Nutrition entérale, and Contract manufacturing

275 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Targeting Chronic Pain Algonist Biotechnologies is a pre-clinical stage biotechnology company, developing novel small molecule therapeutics for chronic pain. Our mission is to develop drugs with similar potency to opioids but without leading to addiction.

85 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Predicting life-changing drugs for patients with cancer Calico Biosystems is on a mission to help pharma companies create effective, affordable drugs faster to counter cancer multi-omics assay, computational modeling, drug efficacy prediction, combination therapy, and Cell and virus-based therapeutics' efficacy

543 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Exploiting a proprietary tech platform to develop biomolecular tools for therapeutic & synthetic biology applications PartitionBio Exploiting a novel proprietary technology platform to develop biomolecular tools for the use in therapeutic and synthetic biology applications. contact@partitionbio.co.uk

328 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Home delivery of drugs and parapharmacy 7 days a week 🚲💊 With Pharmao no need to move, have you delivered in less than an hour, 7 days a week, your medication or your parapharmacy! Msanté, Clickandcollect, Drive, and Webtostore

51 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Smartox Biotechnology is specialized in peptide research and manufacturing Smartox Biotechnology is specialized in peptide research and engineering. Peptide synthesis, physiology, pharmacology, neuroscience, ion channel research, toxin, venomous animals, and screening library

336 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Innovative Process Solutions IPSOMEDIC is a pharmaceutical development company, specializing in innovation in the manufacturing of active pharmaceutical ingredients (APIs). Our objective is to give countries the possibility to reach their pharmaceutical independance. We design tailor-made processes for all stages of industrial production, to become cost efficient, environmental-friendly, and safe: - Continuous chemical reaction - Continuous purification - Continuous crystallization Innovation, Chemical processes, drug substance, and Continuous processes

7 similar entities Type: Startup Activities: manufacturing industry 4.0 Technologies: Synthetic Biology

Innovation at the service of your health and well-being. Pharmaceutical company, R & AMP; D dedicated to the development and marketing of senolytic compounds, food supplements and aging medications, age -related degenerative diseases and cancer.

322 similar entities Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Developing life-changing, innovative therapies for diseases with unmet needs Impel Pharmaceuticals is focused on developing and providing transformative therapies for people suffering from diseases with high unmet needs across various disease areas in addition to the central nervous system (CNS), through the pioneering of an optimized approach to drug delivery. We offer and develop treatments that pair the Company’s proprietary Precision Olfactory Delivery (POD®) technology with well-established therapeutics. Intranasal Drug Delivery, Migraine, Parkinson's Disease, CNS Therapeutics, and Autism

122 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

We deliver solutions AdhexPharma is an independent drug delivery company specialized in Transdermal & Topical patches and Oral Thin Films technologies. AdhexPharma is based in France, with GMP manufacturing facility for European and US market. We have 4 approved products in Europe and North America and a pipeline of 6 candidates, ranging from 505(b)2 / NDA and ANDA in different therapeutical areas: pain, CNS, anesthesia, smoking cessation and HRT. Trandermal, Patch, Oral Thin Film, Drug Development, GMP manufacturing, FDA approved, OTF, ODF, cGMP, TDS, CDMO, and CMO

61 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Bringing new treatments to patients faster and more efficiently. Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. The company acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop them faster in order to accelerate access to new treatments for patients, and to unlock greater value per program.

178 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Your CDMO for API Solutions since 1970 | Our excellence, your trust #oeyt At Seratec, APIs are more than a science. They are a passion. Entrepreneurs of pharmaceutical chemistry since 1970, we have produced pharmaceutical active ingredients (APIS) for the treatment of rare and orphaned diseases with internationally recognized French know-how, we design, develop, carry out and record files of pharmacologically active molecules with the American drug (FDA), European (EMA) and National (EMA). To offer the best of the services, we also provide the production of APIs according to quality standards known as good manufacturing practices (BPF 2 or CGMP). …

23 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

A Biotech Company 100% Focused On Advancing New Therapies For Childhood Cancer A life science company exclusively focused on finding cures for childhood cancer by identifying and developing the most promising projects to create new treatments and drugs. drug development, clinical development, and childhood cancer

295 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Pioneers in complex formulation · Ascil Biopharm is a clinical-stage biotechnology company specializing in innovative drug delivery solutions. We operate as a CDMO, fully equipped for early-stage drug product development, with a GMP facility for clinical batch manufacturing, (aseptic process and terminal sterilization) to fill various containers (e.g. vials, syringes). Our capabilities extend to formulation, device, and analytical development. · Our proprietary Controlled-Release Formulation (CRF) platform technology, is designed to improve the Phy-Chem properties of APIs and excipients under injection conditions, enabling the development of ready-to-use (RTU) controlled-release formulations and ultra-high concentration (UHC) drug products. · Our expertise covers a …

70 similar entities Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology

3D printed personalized medicines MB Therapeutics is a pharmaceutical company that offer patient centric solutions to Develop and produce personalized medicines. MB Therapeutics solution is powered by 3D printing, allowing dosage, shape and API customization in GMP environement Pharmaceutical development, Pharmaceutical 3D printing, and Personalized medicines

63 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

The Medicine Maker celebrates the people, processes and vision that bring new drugs and biologics to market. The development and manufacture of new drugs and biological medicines draws on the talent, passion and experience of a wide range of professionals. The goal of The Medicine Maker is to bring this group into the limelight and, in doing so, to integrate the entire process, from the registration of an Investigational New Drug (IND) or Biologics License Application (BLA) through to the market launch of new therapies, and beyond. pharmaceutical , biopharmaceutical, bioprocess, upstream, downstream, formulation, drug delivery, and dosage form

138 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Medical cannabis: from seed to purified pharmaceutical grade active ingredients Overseed is the first French biotech company to obtain its license from the ANSM to start its R&D process on cannabis production for pharmaceutical purposes. We are a Biotech which combines leading expertise in genetics, agronomy, organic chemistry and pharma with the ambition to have an expert knowledge on the production of therapeutic cannabis. We will produce GACP and GMP certified dried flowers, full spectrum extracts and purified pharmaceutical grade active ingredients for laboratories. Overseed's research and experimentation will answer patients and the health industry expectations to guarantee production sovereignty, …

58 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Centre d'Etudes Biologiques et Pharmaceutiques OUR MISSION: Provide analytical support for all product development phases (human & veterinary medicines + Medical Device) with: Consulting and expertise Formulation development support Analytical method development and validation Stability studies QC testing Veterinary pre-clinical and clinical studies Développement analytique, Etudes de stabilité, Affaires technico-réglementaires, Consulting & expertise, Troubleshooting (pré et post AMM), Etudes précliniques et cliniques vétérinaires, Analytical method development, ICH validation, Stability study, and Quality Control GMP

95 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Design. Formulate. Deliver. ten23 health is the human-centric and sustainable strategic partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow’s medicines. Our sites in Visp and Basel 🇨🇭 support our clients in developing differentiated, stable, usable, and safe injectable treatments for patients. More about us: www.ten23.health biopharmaceuticals, pharmaceutical industry, Contract Manufacturing, Sterile Manufacturing, Aseptic Manufacturing, Drug Device Integration, Analytical Development, Analytical Testing, Molecule Selection, Packaging , and Formulation Development

227 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

CRO specialized in pharmaceutical drugability for research Expertise in Human and Animal health solid form characterization and formulation development. We deliver both experimental support and consulting services to biotechnology and pharmaceutical companies, not-for-profit organizations and complementary CROs. We are member of the association AFSSI, 1st French research center in Life Sciences, as a founding member and member of the board of Directors. Since March 2019 Joel Vacus, Drugabilis CEO & CSO, is vice-President of AFSSI. https://www.afssi.fr/ Feel free to contact us in order to exchange about your preclinical drug development! contact@drugabilis.com Lead optimization, Formulation, and Physical form optimization

66 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Peptide Chemistry company for design, synthesis, stability studies and chemical optimisation (SAR studies)- CIR agrement PEPTIDES, PEPTIDE LIBRARIES AND PROTEINS Innovative chemistry for therapeutic, diagnostic and cosmetic applications GENEPEP is a CRO company (with CIR agreement) focused on peptide synthesis & services : - Tools for nanoparticles & surface functionalization - Custom synthesis of peptides, proteins & peptide libraries - Catalog of toxins, peptides & pseudopeptides - Design & synthesis for SAR studies (optimisation of solubility, stability, efficacy,...) - Stability & solubility tests - Partner of European programs, ANR, FUI etc...

375 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Galenix, a Key pharmaceutical R&D partner, helps you to reduce your timeline by offering innovative solutions DRUG DELIVERY SOLUTIONS - DRUG PRODUCT DEVELOPMENT - LICENSING-OUT OPPORTUNITIES Galenix provides a range of full R&D pharmaceutical services and Drug Delivery Solutions to health companies for fast access of their products on the market. ●●● From the sourcing of the API through the Drug Product development process, including preformulation, formulation, to clinical supplies, quality control, ICH stabilities and regulatory dossier submission for Europe and US FDA registration. Galenix provides its customers drug products “ready to launch” holding a Marketing Authorization. ●●● Galenix Innovations …

52 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Small molecule GLP/GMP manufaturing Roowin is a privately owned Contract Research Organisation (CRO) headquartered at Riom, Auvergne, France. Its core business being in high value added fine chemistry, Roowin offers services in the following areas: • GMP synthesis • Clean room synthesis • Lead optimization • Scale up, process development • Custom synthesis • Analytical chemistry services We are proud to be able to accompany our customers from early drug discovery over process development to medium-scale GMP production, supporting our operations by strong analytical chemistry capabilities. GMP production, Lead Optimization, Clean room synthesis, Custom Synthesis, scale up, and process development

45 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

A Technology Development and Advisory Company Focused on Medical Devices/Biologics Strategic Advisory Services for both large & small medical device/biologics companies including acquisition, licensing, distribution, joint venture agreements Market, Scientific and Clinical Due Diligence Services Business development Services for venture capital, private equity, hedge funds and investment banking clients & their portfolio companies and clients Product/Device development Strategic Product Postioning including licensing, distribtution and market positioning New Company Formation

520 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Restore health and save lives through innovative medicines Rostra strives urgently to bring novel medicines to patients and clinicians with the power to restore health and save lives globally. Through its novel technology platform, Rostra is developing medicines for infectious diseases with an initial focus on invasive fungal infections. Pharmaceutical Discovery & Drug Development and Infectious Disease

59 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

The IV drug-delivery expert Technoflex is the independent leader in the design, production and commercialization of I.V. drug delivery bags (standard or customized) and connectors with FDA and EMEA references. With a devoted R&D team, Technoflex offers a specific high value opportunity of taylored products to its partners.

59 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

HELPING CREATE A HEALTHIER WORLD THROUGH EXCELLENCE As CDMO (Contract and Development Manufacturing Organization), BePharBel Manufacturing contributes to improve the health of all by supplying our pharma partners: - a genuine end-to-end development and manufacturing solution - that facilitates and accelerates drugs availability for patients. Our main activities are: 1) CDMO BePharBel Manufacturing provides an integrated end-to-end solution for the development and manufacturing, under European GMP conditions, of drugs (small molecules and antibiotics) and medical devices. Our expertise field is the development of new formulations and drug formulations over more than 10 different sterile and non-sterile galenic forms (injectables, powder …

36 similar entities Type: Startup Activities: manufacturing deeptech biotech Technologies: Synthetic Biology

BRINGING YOUR SCIENCE TO LIFE CARBOGEN AMCIS leverages its world-class chemistry skills to provide seamless drug substance, drug products development and commercialization services for leading pharmaceutical and biopharmaceutical companies. We help customers create a better world by becoming the partner of choice thanks to our innovative solutions. We offer an array of integrated and customized services operating in a fully cGMP-compliant infrastructure, including dedicated Highly Potent API facilities and a clean room for Antibody Drug Conjugates. Beyond our services, we also provide high-quality Cholesterol and Vitamin D analogs. CARBOGEN AMCIS is owned by Dishman Carbogen Amcis Limited, (India). Learn more …

61 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

BIOMOLECULES NOW, FOR YOUR FUTURE KYLYS is a Life Science Spin-off from the University of Geneva, now ready to step into clinical development. Passionate about science and biotechnology, we are committed to developing a unique technology to deliver highly effective and safe products based on the next generation of hyaluronic acid (HA). Our products are aesthetic (KYLYS Aesthetics) and medical (KYLYS). Our technology can revolutionize HA delivery for medical and surgical needs, in the field of: Aesthetic Rheumatology Reconstructive surgery Drug delivery system Veterinary

59 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Pulmonary drug delivery with near 100% efficiency DP Innovations Ltd is a privately held healthcare company based in Woodside, CA. The main activity of the company is the development of an innovative pulmonary drug delivery system called SPRIN. SPRIN provides pharmaceutical companies with an alternative delivery system to needle injection for high-precision drugs, such as insulin, gene therapy, antivirals, etc.

15 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Cultivate our positive impact Dômes Pharma is an independent, family-owned company that has been active in the pharmaceutical industry since 1947. It employs 400 people in France, England, Germany, Spain and the USA and has a consolidated turnover of 90 million euros. For over 70 years, the Group has been developing, manufacturing and marketing solutions for the health and well-being of pets. The Dômes Pharma Group has 3 complementary areas of expertise that integrate the entire value chain of medicine and cover all distribution channels. Animal Health

60 similar entities Type: SMB Activities: biotech healthtech deeptech Technologies: Synthetic Biology

Pharmaceutical drug development company, focusing on late-stage development for treatment of serious rare diseases. Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry

662 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

NEW FRONTIERS IN NEUROSCIENCE Expertise, Experience, Innovation, Vision, Values. Neurentis PLC is a late-clinical stage UK biotech company, focusing on neuroscience and specialising in the development of novel treatments for mental health and other neurological and psychiatric diseases. Our product pipeline is balanced with 3 products: 1) an advanced lead drug candidate, a prescription pharmaceutical (selegiline), in a transdermal patch, for the treatment of Treatment-Resistant Depression (TRD) in the last stages of drug development, 2) a small molecule agonist of the oxytocin receptors for the treatment of Autism, Chronic and Neuropathic Pain and addiction to alcohol and opioids and 3) …

105 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Affirma Biotech develops new products to overcome the challenge of Multi Drug Resistant and Chronic Infections Affirma Biotech is a start-up company specialized in the discovery and development of new anti-infective drugs via immunomodulation.

438 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

A Sustainable Platform for Specialty Pharma. As a globally operating company headquartered in Germany, CHEPLAPHARM has established a leading and sustainable platform for specialty pharma during the past two decades. We invest worldwide in well-established pharmaceutical brands which have been developed and introduced by research-based pharmaceutical companies. Our deep expertise in this field enables us to sustain the value of these brands for patients and the medical community. In this way we help the research-based pharmaceutical industry divest from older products so they can focus resources on innovation and new product pipelines. This is how we ACHIEVE MORE together. Specialty …

66 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Laboratory of synthesis and isolation of bioactive molecules (Faculty of Pharmacy, University of Tours) Development of new methodological tools for the synthesis and functionalization of heterogeneous entities Synthesis and isolation of molecules with anti-infectious and anti-cancer Innovation in extractive chemistry: centrifugal sharing chromatography, deep eutectic solvents Organic chemistry, extraction of natural products, and medicinal chemistry

60 similar entities Type: Startup Activities: deeptech biotech Technologies: Bio sourced materials

French pharmaceutical laboratory and subcontractor, product and distributes generic drugs and DM Benta Lyon, French pharmaceutical laboratory and subcontractor, produces and distributes generic drugs covering various therapeutic fields, as well as medical devices. For more than 40 years, its 16 -hectare factory in the Aura region has been recognized as an operational center of excellence, specialized in the production of different pharmaceutical forms (dry, pastry, non -sterile liquids). Benta Lyon actively engages every day in relocation and health and industrial reconquest. By favoring manufacturing in France, the laboratory contributes to reducing dependence on imports and guaranteeing the availability of drugs …

Type: SMB Activities: deeptech biotech manufacturing healthtech Technologies: Synthetic Biology

Trusted partner offering integrated continuum services for medicinal products to access the french market #EAP #CUP #MA - French pharmaceutical company to support global pharma to access to the frenck market - Operate as your affiliate in France combining the exploitation, the distribution, the manufacturing & importation in a single integrated continuum process - Independent and family-owned company - Part of DESTAING PARTICIPATIONS GROUP Early Access, Exploitant services, Orphan drug, Rare disease, Distribution, Promotion, Compassionate, and Market Access

64 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Both consulting firm and training organization, ASPE CONSEIL offers advice and services in regulatory business and in quality to companies operating in the fields of medicines, medical devices, food supplements and cosmetic products. Medical devices, drugs, cosmetics, and food supplements

169 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

At Bioscibex, we are redefining bioprocessing with innovative single-use bioreactor solutions tailored for modern biologics and cell therapy manufacturing. Our mission is to empower researchers and manufacturers with tools that simplify processes, enhance scalability, and improve efficiency.

260 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Hemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located in New York City at its state-of-the-art research facility. The Company is a clinical-stage biopharmaceutical group developing new medicines and treatments for life-threatening diseases. Hemogenyx Pharmaceuticals is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development.

59 similar entities Type: Startup Activities: biotech deeptech

better healing - better life Bioretec Ltd. is a medical device company focusing on the development of strong, safe and reliable absorbable and bioresorbable implants for pediatric and adult orthopaedics. Our products are used worldwide, and we continue to further develop materials and products for load-bearing clinical applications. biomaterials, medical, manufacturing, medical devices, implants, absorbable metal, biopolymers, orthopaedics, and pediatric surgery

215 similar entities Type: SMB Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology

Advancing what’s next in nutrition De Novo Foodlabs is a pioneering biotech start-up revolutionising the field of nutrition. Leveraging the power of microbial fermentation, the company creates innovative products that promote better health for both people and the planet. Food design, Product Development, Recombinant proteins, nutrition, health, and alternativeproteins

215 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Belgium biotech company providing unique pipeline of medical devices in OsteoArthritis, skin aging and ophthalmology. Capitalizing on a history of innovation and expertise in exclusive natural chitosan chemistry, KiOmed Pharma, a spinout from KitoZyme, develops a unique pipeline of medical devices that address unmet medical needs in high impact pathologies and major social burdens such as invalidating OsteoArthritis, skin aging and ophthalmology. Medical Devices & Implants, Biomaterials, Rheumatology & Joint Health, Dermatology, Biosurgery, Regenerative Medicine, Ultrapure Chitosan, and Animal-free Chitosan

94 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Delivery of vision care EyeD Pharma is a clinical stage pharmaceutical company dedicated to improving the life of patients suffering from ophthalmic diseases with unmet medical needs such as glaucoma or dry eye. We develop innovative therapeutic solutions based on sustained release polymeric micro-implants and inserts.

65 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Novel small-molecule drugs in immunology, fibrosis and women health Clinical-stage biotech company founded by serial entrepreneurs and owned by private & institutional investors. Discovery and development of new chemical entities with strong IP and worldwide rights targeting indications with high unmet medical need in immunology, fibrosis and women health. Medicinal Chemistry, in vitro Pharmacology, Drug Discovery and Development, Inflammation and autoimmune diseases, IP generation, IBD, Ulcerative Colitis, Crohn's disease, Fibrosis, and Uterine fibroids

249 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Aiming to provide improved treatments for chronic respiratory diseases through new, innovative drug substances Aiming to provide improved treatments for chronic respiratory diseases through new, innovative and patent protected substances, thereby reducing suffering and ameliorating quality of life for patients.

380 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Revolutionizing drug delivery HHC medical is a health tech startup developing a platform technology for targeted and non-invasive drug delivery via wireless electroporation. Drug Delivery, Genetic therapies, and Enabling life-altering therapies

408 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology

Galactica Biotech provides a drug repurposing method to identify novel applications for molecules in the market and in development for major and orphan diseases, reducing risk for patients and time and cost for companies. Our Mission With our specialized knowledge we are targeting to set new standards in the pharmaceutical industry adding value to old drugs and contributing to the health of people. Drug Discovery, Molecule characterization, Drug repurposing, and Novel compound applications

290 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

100% Natural Stability For Your Blood Sugar Levels and Weight With science-backed, 100% natural solutions, we empower journeys toward balanced and healthier lives by optimizing metabolism and making well-being achievable every day. prediabetes, diabetes, blood sugar management, healthtech, obesity, innovation, medical device, biotech, and life science

220 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Making Regenerative Medicine Accessible Roumai Medical is developing next-generation biotechnologies in regenerative medicine and human-machine interface to meet the unmet clinical needs of millions of patients worldwide.

398 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

We have an active and crucial role in raising standards of everyday life, in making people healthier, happier and safer. Sopharma PLC is one of the leading pharmaceuticals company in Bulgaria popular with manufacturing of high-quality medicines, modern businessethic and social responsibility. The highly technological process for development and production of our products is licensed according to the GPP - Good Production Practices.

44 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

We believe that everyone - irrespective of who they are or where they live - deserve medications that work We believe that everyone - irrespective of who they are or where they live - deserve medications that work

215 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

To make disease-modifying treatments available to patients with serious or life-threatening conditions Medibiofarma S.L is a clinical-stage biotechnology company founded in 2016 by a group of professionals with extensive experience in Drug Discovery in the pharmaceutical industry. We aim to generate innovative and high quality research programs based on the modulation of clinically validated therapeutic targets for the treatment of cancer and non-cancer diseases. Medicinal Chemistry, in vitro Pharmacology, Drug Discovery and Development, IP generation, IBD (Colitis, Crohn), Oncology, CNS, and Synaptopathies

540 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Within the Chugai Pharmaceutical Group, Chugai Pharmaceutical Industries is responsible for the development and production functions. We receive the manufacturing process of investigational drugs and products from Chugai Pharmaceutical, and create methods and mechanisms that can be actually produced in the factory, and carry out the associated quality control and evaluation. In this way, we play an essential role in turning ideas-stage medicines into real-life products that are useful to our patients. Pharmaceuticals, New Drug Development, Global Enterprises, Biopharmaceuticals, Low-Mid-Molecular Drugs, Pharmaceutical Manufacturing, Production Technology, IT Engineers, Engineers, Quality Control, and Quality Assurance

63 similar entities Type: SMB Activities: it services Technologies: Synthetic Biology

Innovation in medical needs. Inmedical Therapeutics es un fabricante de productos médicos y soluciones en formato hidrogel ubicado en Vitoria. Biotecnología, Endoscopia, Farmacéutica, and Producto Médico

131 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

A Swiss Biotech company with a commitment to improving patient outcomes and quality of life in high unmet need diseases Mosanna is a Swiss Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach. We carefully select innovative medicines for further development using the best contract research organisations in the specific specialised field. Our first goal is to bring an effective and well tolerated medicinal nasal spray to Metabolic Obstructive Sleep Apnea patients.

99 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Precision Drugs against Eucaryotic Pathogens ASTRA Therapeutics is a Drug Discovery company with a mission to design and develop novel, precision engineered drugs against a whole range of Eukaryotic Pathogens.

505 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Accelerating drug discovery to transform patients' lives Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases

605 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Innovating to Enhance Quality of Life Fitabeo Therapeutics is a clinical-stage specialty pharmaceutical company that develops and commercialises a differentiated portfolio of innovative medicines focusing on indications where existing treatments are inadequate for the target population. It deploys breakthrough technologies to develop medicines that enable patient autonomy, decentralise patient care and provide superior health outcomes. Oral Thin Films, Geriatrics, Paediatrics, Patient autonomy, Equitable Access, Innovative medicines, Medication adherence, Central Nervous System, Women's Health, and Neurology

315 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

we develop for patients Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe. Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections. Debiopharm completed the development and has licensed out 2 compounds: - Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur® 1, 3 and 6-month formulation and Moapar®/Salcacyl® -Oxaliplatin, the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat® If your university …

79 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Integrated Drug Discovery | Drug Development | Contract Research Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development. biotechnology, pharmaceuticals, drug discovery, preclinical research, bioanalytical development services, bioinformatics, systems biology, proteins, genomics, proteomics, autoimmune disorders, regulatory studies, medicinal chemistry, agrochemical, industrial chemistry, and assay development&screening

504 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Advancing drug discovery and development through integrated laboratory, analytical, and clinical services Frontage Laboratories, Inc. is a CRO that provides integrated, science-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of molecules through development and file regulatory submissions in the United …

107 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

A better future. For everyone. Egualia (formerly Assogenerici) is the Italian Federation of Industries for Accessible Medicines which today represents more than fifty companies, over 95% of the companies producing generic, biosimilar and value-added medicines. Founded in 1993, it is a member of the European association of the sector, Medicines for Europe, and welcomes multinational and Italian companies present throughout the territory, which produce both for the domestic and foreign markets, as well as companies engaged in the production of drugs on behalf of third parties for the entire pharmaceutical industry. Generics and biosimilars cover 80% of therapeutic areas and …

63 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

dedicated to good health® Genix Pharma (Pvt.) Ltd is a leading Pharmaceutical manufacturer & marketing company, based in Pakistan with its business expanding throughout Asian & African Markets, after its establishment in 2004, Genix Pharma has been recognized as the fastest growing Pharmaceutical Company in its earliest years, it has been ranked among the top 40 companies including MNC’s, We have a work force of more than 1400 professionally trained and highly qualified employees, state of the art manufacturing facility, Well-furnished Quality Control department with top of the line and highly sophisticated Equipment, motivated by a passion to succeed, our …

154 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Driven by innovation to contribute to a healthier and happier life We share a deep commitment to service and customer service, which, combined with our professionalism, helps us achieve our primary objective: giving a longer, healthier, happier life to society by offering safe and efficacious drugs. We are able to achieve this goal through research and analysis, as well as an understanding of the needs of our patients, professionals, distributors and institutional representatives. Medicamentos de prescripción, Nutraceuticos, and Productos farmacéuticos

153 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

As one of core operating companies of the Sumitomo Corporation Group, we contribute to enriching lives and the world through the improvement of the health and well-being by linking pharmaceutical companies in Japan and overseas, leveraging its global network and expertise.

160 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology New Materials

Innovation for people Created in 1963, Farmaindustria is the National Association of the Pharmaceutical Industry established in Spain. It brings together most of the innovative pharmaceutical laboratories established in Spain, which accounts for almost all sales of prescription drugs under patent in the country. farmacia, investigación y desarrollo, industria, innovación, salud, sanidad, health, pharma, healthcare, laboratorios, medicamentos, fármacos, pharmaceuticals, medicine, I+D, vacunas, vaccines, and industria farmacéutica

70 similar entities Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology

Starpharma is a global biopharmaceutical company and a world leader in the development of dendrimers. Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for respiratory viruses, DEP® drug delivery and VivaGel®. Medical Devices, Pharmaceuticals, and Dendrimer Drug Delivery

61 similar entities Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology

The natural solution for drug delivery DelSiTech is a drug delivery and drug development company based in Turku, Finland. DelSiTech has developed a unique proprietary technology making it a world leader in advanced biodegradable silica-based drug delivery. The technology has successfully been applied to the controlled release of small molecules, biopharmaceuticals and viral vectors with a focus on parenteral and local administration. We can work with you from early feasibility testing to clinical proof of concept; the technology can also be licensed to industry partners. With the DelSiTechTMSilica Matrix, we can create novel products, provide alternative administration opportunities, and extend …

21 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology